Amelioration of Diabetes in Mice after Single-Donor Islet Transplantation Using the Controlled Release of Gelatinized FGF-2

Fibroblast growth factor (FGF)-2 has been recognized to be a key element involved in angiogenesis and a putative factor involved in stem cell-mediated islet regeneration. However, the usefulness of FGF-2 in an islet transplantation setting has not yet been explored. We therefore evaluated the effect...

Full description

Bibliographic Details
Main Authors: Jorge David Rivas-Carrillo, Nalu Navarro-Alvarez, Alejandro Soto-Gutierrez, Teru Okitsu, Yong Chen, Yasuhiko Tabata, Haruo Misawa, Hirofumi Noguchi, Shinichi Matsumoto, Noriaki Tanaka, Naoya Kobayashi M.D., Ph.D.
Format: Article
Language:English
Published: SAGE Publishing 2006-11-01
Series:Cell Transplantation
Online Access:https://doi.org/10.3727/000000006783981323
id doaj-e71888810de74844928795040ba3bc6c
record_format Article
spelling doaj-e71888810de74844928795040ba3bc6c2020-11-25T03:46:27ZengSAGE PublishingCell Transplantation0963-68971555-38922006-11-011510.3727/000000006783981323Amelioration of Diabetes in Mice after Single-Donor Islet Transplantation Using the Controlled Release of Gelatinized FGF-2Jorge David Rivas-Carrillo0Nalu Navarro-Alvarez1Alejandro Soto-Gutierrez2Teru Okitsu3Yong Chen4Yasuhiko Tabata5Haruo Misawa6Hirofumi Noguchi7Shinichi Matsumoto8Noriaki Tanaka9Naoya Kobayashi M.D., Ph.D.10 Department of Surgery, Okayama University Graduate School of Medicine and Dentistry, Okayama 700-8558, Japan Department of Surgery, Okayama University Graduate School of Medicine and Dentistry, Okayama 700-8558, Japan Department of Surgery, Okayama University Graduate School of Medicine and Dentistry, Okayama 700-8558, Japan Department of Transplant Surgery, Kyoto University Hospital, Kyoto 606-8507, Japan Department of Surgery, Okayama University Graduate School of Medicine and Dentistry, Okayama 700-8558, Japan Institute for Frontier Medical Sciences, Kyoto University, Kyoto 606-8507, Japan Department Department of Orthopaedic Surgery, Okayama University Graduate School of Medicine and Dentistry, Okayama 700-8558, Japan Department of Advanced Medicine in Biotechnology and Robotics, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan Second Department of Surgery, Fujita Health University, Toyoake, Aichi 470-11, Japan Department of Surgery, Okayama University Graduate School of Medicine and Dentistry, Okayama 700-8558, Japan Department of Surgery, Okayama University Graduate School of Medicine and Dentistry, Okayama 700-8558, JapanFibroblast growth factor (FGF)-2 has been recognized to be a key element involved in angiogenesis and a putative factor involved in stem cell-mediated islet regeneration. However, the usefulness of FGF-2 in an islet transplantation setting has not yet been explored. We therefore evaluated the effect of FGF-2 on both islet culture and islet transplantation. Isolated islets were cultured in the presence of 100 ng/ml FGF-2 for a week and then the glucose-responding insulin secretion and insulin contents were measured. Gelatinized FGF-2 (100 ng), which allowed the controlled release of FGF-2, was used for islet transplantation of streptozotocin-induced diabetic mice. Islets (150 IEQ), obtained from a single donor, mixed with gelatinized FGF-2, were transplanted into the subrenal capsule of the mice and the animals were observed for 30 days. Revascularization around the islet grafts was examined. The blood glucose levels were measured and the intraperitoneal glucose tolerance test (IPGTT) was performed. The supplementation of FGF-2 maintained proper insulin secretion and insulin contents in an in vitro culture. The use of gelatinized FGF-2 facilitated revascularization and favorable islet engraftment, thus resulting in an amelioration of the blood glucose levels in diabetic mice. The utilization of FGF-2 showed increased contents of insulin in the islet grafts and revealed a similar pattern as that of normal healthy mice in IPGTT. In contrast, the transplantation of islets without FGF-2 supplementation showed poor revascularization and failed to control the blood glucose levels in the diabetic mice.https://doi.org/10.3727/000000006783981323
collection DOAJ
language English
format Article
sources DOAJ
author Jorge David Rivas-Carrillo
Nalu Navarro-Alvarez
Alejandro Soto-Gutierrez
Teru Okitsu
Yong Chen
Yasuhiko Tabata
Haruo Misawa
Hirofumi Noguchi
Shinichi Matsumoto
Noriaki Tanaka
Naoya Kobayashi M.D., Ph.D.
spellingShingle Jorge David Rivas-Carrillo
Nalu Navarro-Alvarez
Alejandro Soto-Gutierrez
Teru Okitsu
Yong Chen
Yasuhiko Tabata
Haruo Misawa
Hirofumi Noguchi
Shinichi Matsumoto
Noriaki Tanaka
Naoya Kobayashi M.D., Ph.D.
Amelioration of Diabetes in Mice after Single-Donor Islet Transplantation Using the Controlled Release of Gelatinized FGF-2
Cell Transplantation
author_facet Jorge David Rivas-Carrillo
Nalu Navarro-Alvarez
Alejandro Soto-Gutierrez
Teru Okitsu
Yong Chen
Yasuhiko Tabata
Haruo Misawa
Hirofumi Noguchi
Shinichi Matsumoto
Noriaki Tanaka
Naoya Kobayashi M.D., Ph.D.
author_sort Jorge David Rivas-Carrillo
title Amelioration of Diabetes in Mice after Single-Donor Islet Transplantation Using the Controlled Release of Gelatinized FGF-2
title_short Amelioration of Diabetes in Mice after Single-Donor Islet Transplantation Using the Controlled Release of Gelatinized FGF-2
title_full Amelioration of Diabetes in Mice after Single-Donor Islet Transplantation Using the Controlled Release of Gelatinized FGF-2
title_fullStr Amelioration of Diabetes in Mice after Single-Donor Islet Transplantation Using the Controlled Release of Gelatinized FGF-2
title_full_unstemmed Amelioration of Diabetes in Mice after Single-Donor Islet Transplantation Using the Controlled Release of Gelatinized FGF-2
title_sort amelioration of diabetes in mice after single-donor islet transplantation using the controlled release of gelatinized fgf-2
publisher SAGE Publishing
series Cell Transplantation
issn 0963-6897
1555-3892
publishDate 2006-11-01
description Fibroblast growth factor (FGF)-2 has been recognized to be a key element involved in angiogenesis and a putative factor involved in stem cell-mediated islet regeneration. However, the usefulness of FGF-2 in an islet transplantation setting has not yet been explored. We therefore evaluated the effect of FGF-2 on both islet culture and islet transplantation. Isolated islets were cultured in the presence of 100 ng/ml FGF-2 for a week and then the glucose-responding insulin secretion and insulin contents were measured. Gelatinized FGF-2 (100 ng), which allowed the controlled release of FGF-2, was used for islet transplantation of streptozotocin-induced diabetic mice. Islets (150 IEQ), obtained from a single donor, mixed with gelatinized FGF-2, were transplanted into the subrenal capsule of the mice and the animals were observed for 30 days. Revascularization around the islet grafts was examined. The blood glucose levels were measured and the intraperitoneal glucose tolerance test (IPGTT) was performed. The supplementation of FGF-2 maintained proper insulin secretion and insulin contents in an in vitro culture. The use of gelatinized FGF-2 facilitated revascularization and favorable islet engraftment, thus resulting in an amelioration of the blood glucose levels in diabetic mice. The utilization of FGF-2 showed increased contents of insulin in the islet grafts and revealed a similar pattern as that of normal healthy mice in IPGTT. In contrast, the transplantation of islets without FGF-2 supplementation showed poor revascularization and failed to control the blood glucose levels in the diabetic mice.
url https://doi.org/10.3727/000000006783981323
work_keys_str_mv AT jorgedavidrivascarrillo ameliorationofdiabetesinmiceaftersingledonorislettransplantationusingthecontrolledreleaseofgelatinizedfgf2
AT nalunavarroalvarez ameliorationofdiabetesinmiceaftersingledonorislettransplantationusingthecontrolledreleaseofgelatinizedfgf2
AT alejandrosotogutierrez ameliorationofdiabetesinmiceaftersingledonorislettransplantationusingthecontrolledreleaseofgelatinizedfgf2
AT teruokitsu ameliorationofdiabetesinmiceaftersingledonorislettransplantationusingthecontrolledreleaseofgelatinizedfgf2
AT yongchen ameliorationofdiabetesinmiceaftersingledonorislettransplantationusingthecontrolledreleaseofgelatinizedfgf2
AT yasuhikotabata ameliorationofdiabetesinmiceaftersingledonorislettransplantationusingthecontrolledreleaseofgelatinizedfgf2
AT haruomisawa ameliorationofdiabetesinmiceaftersingledonorislettransplantationusingthecontrolledreleaseofgelatinizedfgf2
AT hirofuminoguchi ameliorationofdiabetesinmiceaftersingledonorislettransplantationusingthecontrolledreleaseofgelatinizedfgf2
AT shinichimatsumoto ameliorationofdiabetesinmiceaftersingledonorislettransplantationusingthecontrolledreleaseofgelatinizedfgf2
AT noriakitanaka ameliorationofdiabetesinmiceaftersingledonorislettransplantationusingthecontrolledreleaseofgelatinizedfgf2
AT naoyakobayashimdphd ameliorationofdiabetesinmiceaftersingledonorislettransplantationusingthecontrolledreleaseofgelatinizedfgf2
_version_ 1724506356446134272